This is a demo store. No orders will be fulfilled.

LFM-A13 - ≥98%(HPLC), high purity , CAS No.62004-35-7

    Grade & Purity:
  • ≥98%(HPLC)
In stock
Item Number
L286934
Grouped product items
SKU Size
Availability
Price Qty
L286934-5mg
5mg
3
$124.90
L286934-10mg
10mg
3
$191.90
L286934-25mg
25mg
3
$431.90
L286934-50mg
50mg
1
$670.90
L286934-100mg
100mg
2
$1,207.90
L286934-250mg
250mg
2
$2,716.90

Potent, selective BTK inhibitor

Basic Description

Synonyms AKOS028108222 | alpha-Cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide | KBio3_001038 | HMS3370M16 | L0309 | 2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide | Bio2_000450 | KBio2_000579 | KBio2_005715 | KBio3_001037 | Q27166836 | KBioG
Specifications & Purity ≥98%(HPLC)
Biochemical and Physiological Mechanisms Potent and selective inhibitor of Bruton's tyrosine kinase (BTK). Inhibits recombinant BTK with an IC50value of 2.5μM and has no activity on other protein kinases ( including JAK1, JAK3, HCK, EGFR kinase and insulin receptor kinase) at concentrations of u
Storage Temp Protected from light,Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

Product description:

A potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton’s Tyrosine Kinase (BTK; IC50 = 17.2 µM for human BTK in vitro and IC50 = 2.5 µM for recombinant BTK). Also inhibits Polo-like kinase in an ATP-competitive manner (IC50 = 10 µM and 61 µM for Plx1 and Plk3, respectively), and displays antitumor properties. Does not affect the enzymatic activity of other protein tyrosine kinases, including EGFR, HCK, IRK JAK1, and JAK3 even at concentrations of 278 µM. Enhances the chemosensitivity of BTK-positive B-lineage leukemia cells to ceramide- and vincristine-induced apoptosis.

A potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton′s tyrosine kinase (BTK; IC50 = 17.2 µM for human BTK in vitro and IC50 = 2.5 µM for recombinant BTK). Also inhibits Polo-like kinase in an ATP-competitive manner (IC50 = 10 µM and 61 µM for Plx1 and Plk3, respectively), and displays antitumor properties. Does not affect the enzymatic activity of other protein tyrosine kinases, including EGFR, HCK, IRK JAK1, and JAK3 even at concentrations of 278 µM. Enhances the chemosensitivity of BTK-positive B-lineage leukemia cells to ceramide- and vincristine-induced apoptosis.


Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Benzenoids
Class Benzene and substituted derivatives
Subclass Anilides
Intermediate Tree Nodes Not available
Direct Parent Anilides
Alternative Parents N-arylamides  Bromobenzenes  Aryl bromides  Vinylogous acids  Secondary carboxylic acid amides  Nitriles  Enols  Organopnictogen compounds  Organobromides  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular Framework Aromatic homomonocyclic compounds
Substituents Anilide - N-arylamide - Bromobenzene - Halobenzene - Aryl bromide - Aryl halide - Vinylogous acid - Carboxamide group - Secondary carboxylic acid amide - Carboxylic acid derivative - Enol - Carbonitrile - Nitrile - Organopnictogen compound - Organic oxygen compound - Hydrocarbon derivative - Organic nitrogen compound - Organic oxide - Carbonyl group - Organohalogen compound - Organobromide - Organonitrogen compound - Organooxygen compound - Aromatic homomonocyclic compound
Description This compound belongs to the class of organic compounds known as anilides. These are organic heterocyclic compounds derived from oxoacids RkE(=O)l(OH)m (l not 0) by replacing an OH group by the NHPh group or derivative formed by ring substitution.
External Descriptors Not available

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Names and Identifiers

Pubchem Sid 488201704
Pubchem Sid Url https://pubchem.ncbi.nlm.nih.gov/substance/488201704
IUPAC Name 2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide
INCHI InChI=1S/C11H8Br2N2O2/c1-6(16)8(5-14)11(17)15-10-4-7(12)2-3-9(10)13/h2-4,16H,1H3,(H,15,17)
InChIKey UVSVTDVJQAJIFG-UHFFFAOYSA-N
Smiles CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O
Isomeric SMILES CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O
Molecular Weight 360
Reaxy-Rn 10678941
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=10678941&ln=

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

9 results found

Lot Number Certificate Type Date Item
K2225712 Certificate of Analysis Aug 15, 2022 L286934
C2519733 Certificate of Analysis Aug 15, 2022 L286934
K2225676 Certificate of Analysis Aug 15, 2022 L286934
K2225677 Certificate of Analysis Aug 15, 2022 L286934
K2225604 Certificate of Analysis Aug 15, 2022 L286934
K2225780 Certificate of Analysis Aug 15, 2022 L286934
K2225664 Certificate of Analysis Aug 15, 2022 L286934
K2225667 Certificate of Analysis Aug 15, 2022 L286934
K2225779 Certificate of Analysis Aug 15, 2022 L286934

Chemical and Physical Properties

Solubility Solvent:DMSO, Max Conc. mg/mL: 36, Max Conc. mM: 100
Sensitivity light & heat sensitive
Molecular Weight 360.000 g/mol
XLogP3 3.800
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 2
Exact Mass 359.893 Da
Monoisotopic Mass 357.895 Da
Topological Polar Surface Area 73.100 Ų
Heavy Atom Count 17
Formal Charge 0
Complexity 386.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 1
The total count of all stereochemical bonds 1
Covalently-Bonded Unit Count 1

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.